IP Library Granted Patent US 7,208,571
Granted Patent B2
US 7,208,571 · App. 11/011,880 · Granted Apr 24, 2007

In vivo production of cyclic peptides

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,208,571
App. No.
11/011,880
Granted
Apr 24, 2007
Kind
B2
Abstract

The present invention relates ti methods and compositions utilizing inteins to generated libraries of cyclic peptides in vivo.

Claims (14)

1. An isolated cell comprising:

a cyclic peptide consisting of three amino acids, wherein at least one of said amino acids is a Ser, Thr or Cys.

2. The isolated cell of claim 1 , wherein said cell further comprises:

a nucleic acid encoding a fusion protein comprising, in order:

a) a C-terminal intein domain;

b) a peptide; and

c) a N-terminal intein domain;

wherein said fusion protein undergoes a reaction to produce said cyclic peptide.

3. The isolated cell of claim 1 , wherein said cell is a mammalian cell.

4. The isolated cell of claim 2 , wherein said fusion protein is encoded by retroviral vector.

5. The isolated cell of claim 2 , wherein said cell is a mammalian cell.

6. An isolated cell comprising a cyclic peptide consisting of three amino acids, wherein at least one of said amino acids is a Ser, Thr or Cys, and wherein said cyclic peptide is produced as a result of a cyclization reaction of a fusion protein comprising, in order: a) a C-terminal intein domain; b) a peptide; and c) a N-terminal intein domain.

7. The isolated cell of claim 6 , wherein said cell is a mammalian cell.

8. The isolated cell of claim 6 , wherein said fusion protein is encoded by retroviral vector.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 13, 2004
From: KINSELLA, TODD M.
To: RIGEL PHARMACEUTICALS, INC.
Reel/Frame 016101/0831 →